Primary Site >> Colorectal Cancer

Gene >> BCL9

Journal: Cancer Res. 2004 Dec 1;64(23):8496-501.
Title: Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
Author: Adachi, Shungo|Jigami, Takafumi|Yasui, Toshio|Nakano, Tetsuhiro|Ohwada, Susumu|Omori, Yoshihiro|Sugano, Sumio|Ohkawara, Bisei|Shibuya, Hiroshi|Nakamura, Tsutomu|Akiyama, Tetsu
PMID: 15574752
Journal: Development. 2004 Sep;131(17):4393-400.
Title: Identification and in vivo role of the Armadillo-Legless interaction.
Author: Hoffmans, Raymond|Basler, Konrad
PMID: 15294866
Journal: Int J Mol Med. 2006 Mar;17(3):529-32.
Title: FGF signaling inhibitor, SPRY4, is evolutionarily conserved target of WNT signaling pathway in progenitor cells.
Author: Katoh, Yuriko|Katoh, Masaru
PMID: 16465403
Journal: BMC Cancer. 2006 Oct 4;6:236.
Title: Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
Author: Fuerer, Christophe|Homicsko, Krisztian|Lukashev, Alexander N|Pittet, Anne-Laure|Iggo, Richard D
PMID: 17020613
Journal: Mech Dev. 2007 Jan;124(1):59-67.
Title: BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling.
Author: Hoffmans, Raymond|Basler, Konrad
PMID: 17113272
Journal: Cancer Sci. 2007 Jan;98(1):83-7.
Title: Up-regulation of a BCL9-related beta-catenin-binding protein, B9L, in different stages of sporadic colorectal adenoma.
Author: Sakamoto, Ichiro|Ohwada, Susumu|Toya, Hiroyuki|Togo, Nozomi|Kashiwabara, Kenji|Oyama, Tetsunari|Nakajima, Takashi|Ito, Hideaki|Adachi, Shungo|Jigami, Takafumi|Akiyama, Tetsu
PMID: 17129358
Journal: BMC Cancer. 2008 Jul 15;8:199.
Title: The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.
Author: de la Roche, Marc|Worm, Jesper|Bienz, Mariann
PMID: 18627596
Journal: Cancer Res. 2009 Oct 1;69(19):7577-86.
Title: BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells.
Author: Mani, Mala|Carrasco, Daniel E|Zhang, Yunyu|Takada, Kohichi|Gatt, Moshe E|Dutta-Simmons, Jui|Ikeda, Hiroshi|Diaz-Griffero, Felipe|Pena-Cruz, Victor|Bertagnolli, Monica|Myeroff, Lois L|Markowitz, Sanford D|Anderson, Kenneth C|Carrasco, Daniel R
PMID: 19738061
Journal: Gastroenterology. 2011 Oct;141(4):1359-70, 1370.e1-3.
Title: BCL9-2 promotes early stages of intestinal tumor progression.
Author: Brembeck, Felix H|Wiese, Maria|Zatula, Nathalie|Grigoryan, Tamara|Dai, Yiyang|Fritzmann, Johannes|Birchmeier, Walter
PMID: 21703997
Journal: Nat Commun. 2012 Feb 21;3:680.
Title: An intrinsically labile alpha-helix abutting the BCL9-binding site of beta-catenin is required for its inhibition by carnosic acid.
Author: de la Roche, Marc|Rutherford, Trevor J|Gupta, Deepti|Veprintsev, Dmitry B|Saxty, Barbara|Freund, Stefan M|Bienz, Mariann
PMID: 22353711
Journal: Sci Transl Med. 2012 Aug 22;4(148):148ra117.
Title: Targeted disruption of the BCL9/beta-catenin complex inhibits oncogenic Wnt signaling.
Author: Takada, Kohichi|Zhu, Di|Bird, Gregory H|Sukhdeo, Kumar|Zhao, Jian-Jun|Mani, Mala|Lemieux, Madeleine|Carrasco, Daniel E|Ryan, Jeremy|Horst, David|Fulciniti, Mariateresa|Munshi, Nikhil C|Xu, Wenqing|Kung, Andrew L|Shivdasani, Ramesh A|Walensky, Loren D|Carr
PMID: 22914623
Journal: Cell Rep. 2013 Dec 26;5(6):1650-63.
Title: LATS2 suppresses oncogenic Wnt signaling by disrupting beta-catenin/BCL9 interaction.
Author: Li, Jiong|Chen, Xiaohong|Ding, Xiangming|Cheng, Yingduan|Zhao, Bin|Lai, Zhi-Chun|Al Hezaimi, Khalid|Hakem, Razqallah|Guan, Kun-Liang|Wang, Cun-Yu
PMID: 24360964
Journal: Cancer Res. 2014 Mar 1;74(5):1495-505.
Title: LEF1 and B9L shield beta-catenin from inactivation by Axin, desensitizing colorectal cancer cells to tankyrase inhibitors.
Author: de la Roche, Marc|Ibrahim, Ashraf E K|Mieszczanek, Juliusz|Bienz, Mariann
PMID: 24419084
Journal: Anticancer Res. 2014 Oct;34(10):5517-21.
Title: Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.
Author: Vanacker, Leen|Smeets, Dominiek|Hoorens, Anne|Teugels, Erik|Algaba, Roberto|Dehou, Marie Francoise|De Becker, Ann|Lambrechts, Diether|De Greve, Jacques
PMID: 25275049
Journal: Cancer Res. 2014 Oct 1;74(19):5351-8.
Title: Crosstalk between microRNA30a/b/c/d/e-5p and the canonical Wnt pathway: implications for multiple myeloma therapy.
Author: Zhao, Jian-Jun|Carrasco, Ruben D
PMID: 25228654
Journal: Breast Cancer Res. 2015 Sep 17;17:128.
Title: Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
Author: Elsarraj, Hanan S|Hong, Yan|Valdez, Kelli E|Michaels, Whitney|Hook, Marcus|Smith, William P|Chien, Jeremy|Herschkowitz, Jason I|Troester, Melissa A|Beck, Moriah|Inciardi, Marc|Gatewood, Jason|May, Lisa|Cusick, Therese|McGinness, Marilee|Ricci, Lawrence|Fa
PMID: 26384318
Journal: Vestn Ross Akad Med Nauk. 2015;(4):475-83.
Title: [beta-Catenin: Structure, Function and Role in Malignant Transformation of Epithelial Cells].
Author: Isaeva, A V|Zima, A P|Shabalova, I P|Ryazantseva, N V|Vasil'eva, O A|Kasoayn, K T|Saprina, T V|Latypova, V N|Berezkina, I S|Novitskii, V V
PMID: 26710532
Journal: EBioMedicine. 2015 Nov 19;2(12):1846-7.
Title: Tuning WNT-beta-catenin signaling via BCL9 proteins for targeting colorectal cancer cells.
Author: Beaulieu, Jean-Francois
PMID: 26844253
Journal: EBioMedicine. 2015 Oct 30;2(12):1932-43.
Title: BCL9/9L-beta-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer.
Author: Moor, Andreas E|Anderle, Pascale|Cantu, Claudio|Rodriguez, Patrick|Wiedemann, Norbert|Baruthio, Frederique|Deka, Jurgen|Andre, Sylvie|Valenta, Tomas|Moor, Matthias B|Gyorffy, Balazs|Barras, David|Delorenzi, Mauro|Basler, Konrad|Aguet, Michel
PMID: 26844272
Journal: J Surg Res. 2016 Jun 1;203(1):193-205.
Title: The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway.
Author: Monin, Malte B|Krause, Petra|Stelling, Robin|Bocuk, Derya|Niebert, Sabine|Klemm, Florian|Pukrop, Tobias|Koenig, Sarah
PMID: 27338550
Journal: Oncotarget. 2016 Dec 6;7(49):80612-80632.
Title: The role of Pygo2 for Wnt/ss-catenin signaling activity during intestinal tumor initiation and progression.
Author: Talla, Suranand B|Brembeck, Felix H
PMID: 27811361
Journal: Oncotarget. 2017 Apr 18;8(16):25885-25896.
Title: HIF-1alpha activates hypoxia-induced BCL-9 expression in human colorectal cancer cells.
Author: Tan, Zhen|Huang, Quan|Zang, Jia|Teng, Shi-Feng|Chen, Tian-Rui|Wei, Hai-Feng|Song, Dian-Wen|Liu, Tie-Long|Yang, Xing-Hai|Fu, Chuan-Gang|Hu, Zhi-Qian|Zhou, Wang|Yan, Wang-Jun|Xiao, Jian-Ru
PMID: 27121066
Journal: Genome Med. 2017 May 24;9(1):46.
Title: Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1.
Author: Sveen, Anita|Johannessen, Bjarne|Tengs, Torstein|Danielsen, Stine A|Eilertsen, Ina A|Lind, Guro E|Berg, Kaja C G|Leithe, Edward|Meza-Zepeda, Leonardo A|Domingo, Enric|Myklebost, Ola|Kerr, David|Tomlinson, Ian|Nesbakken, Arild|Skotheim, Rolf I|Lothe, Ragnh
PMID: 28539123
Journal: Int J Mol Med. 2018 Aug;42(2):713-725.
Title: Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/betacatenin signaling activation (Review).
Author: Katoh, Masaru
PMID: 29786110